Petmed Express Inc  

(Public, NASDAQ:PETS)   Watch this stock  
Find more results for PETS
+0.15 (1.16%)
Apr 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 12.88 - 13.26
52 week 12.13 - 17.75
Open 12.97
Vol / Avg. 155,232.00/238,168.00
Mkt cap 264.49M
P/E 14.55
Div/yield 0.17/5.19
EPS 0.90
Shares 20.19M
Beta 1.25
Inst. own 77%

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 9.07% 7.53%
Operating margin 14.07% 11.85%
EBITD margin - 12.33%
Return on average assets 23.82% 20.90%
Return on average equity 26.80% 23.65%
Employees 206 -
CDP Score - -


1441 S.W. 29th Avenue
United States - Map
+1-954-9795995 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


PetMed Express, Inc. (PetMed Express) and its subsidiaries, doing business as 1-800-PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. The Company markets its products through national television, online, and direct mail/print advertising campaigns. The Company offers a selection of products for dogs and cats. As of March 31, 2013, the Company´┐Żs product line contains approximately stock keeping units (SKUS). These products include brands of medication, such as Frontline Plus, K9 Advantix II, Advantage II, Heartgard Plus, Sentinel, Revolution, and Rimadyl. It also offers for sale additional pet supplies on its Website, which are drop shipped to its customers by third parties. These pet supplies include food, beds, crates, stairs, strollers, and other pet supplies.

Officers and directors

Robert C. Schweitzer Independent Chairman of the Board
Age: 67
Bio & Compensation  - Reuters
Menderes Akdag President, Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Bruce S. Rosenbloom Chief Financial Officer, Treasurer
Age: 44
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Frank J. Formica Independent Director
Age: 69
Bio & Compensation  - Reuters
Gian M. Fulgoni Independent Director
Age: 65
Bio & Compensation  - Reuters
Ronald J. Korn Independent Director
Age: 73
Bio & Compensation  - Reuters